first human implant of heartware hvad, page-10

re: first operation only 85 minutes This company has a brilliant product far superior to Ventracor.

It has no capital issues, sharerholders, investors and the mob are falling over themselves to get big lines of stock. None are available.

The market potential of this product is such that the capital required - $20m- could be raised with one phone call.

I am a big holder. My average entry is 41c. I have never sold a share. In fact I picked up a few more on Friday above $1.20.

There are no sellers and a handful of daytraders looking for a quick few cents.

This may well be a $3-5 share in the not too distant future. Anyway that's what I bought believing.

Anyone want to sell any volume? Let me know.